-
公开(公告)号：US11608364B2
公开(公告)日：2023-03-21
申请号：US17051299
申请日：2019-04-29
Applicant: DSM IP ASSETS B.V.
Inventor： Johannes Gustaaf Ernst Van Leeuwen , Viktor Marius Boer , Priscilla Zwartjens , Jos Van Vugt , René Marcel De Jong
Abstract: The disclosure provides a recombinant cell capable of producing a steviol glycoside, wherein the cell comprises a nucleic acid coding for a variant of a parent polypeptide, wherein the variant has steviol glycoside transport mediating activity, wherein the variant comprises an amino acid sequence which, when aligned with the amino acid sequence of the parent polypeptide, comprises at least one modification of the amino acid residue corresponding to any of the amino acids in the amino acid sequence of the parent polypeptide, wherein the variant has an improved ability to produce rebaudioside M and optionally other steviol glycosides extracellularly if compared with the parent polypeptide when measured under the same conditions.
-
公开(公告)号：US11225647B2
公开(公告)日：2022-01-18
申请号：US16345129
申请日：2017-10-26
Applicant: DSM IP ASSETS B.V.
Abstract: The present invention relates a variant polypeptide having geranylgeranyl pyrophosphate synthase activity, which variant polypeptide comprises an amino acid sequence which, when aligned with a geranylgeranyl pyrophosphate synthase comprising the sequence set out in SEQ ID NO: 1, comprises at least one substitution of an amino acid residue corresponding to any of amino acids at positions
92, 100 or 235
said positions being defined with reference to SEQ ID NO: 1 and wherein the variant has one or more modified properties as compared with a reference polypeptide having geranylgeranyl pyrophosphate synthase activity. A variant polypeptide of the invention may be used in a recombinant host for the production of steviol or a steviol glycoside.-
公开(公告)号：US11203764B2
公开(公告)日：2021-12-21
申请号：US16938483
申请日：2020-07-24
Applicant: DSM IP ASSETS B.V.
Abstract: The present invention relates a variant polypeptide having kaurenoic acid 13-hydroxylase activity, which variant polypeptide comprises an amino acid sequence which, when aligned with a kaurenoic acid 13-hydroxylase comprising the sequence set out in SEQ ID NO: 1, comprises at least one substitution of an amino acid residue corresponding to any of amino acids 72, 85, 108, 127, 129, 141, 172, 195, 196, 197, 199, 226, 236, 291, 302, 361 or 464, said positions being defined with reference to SEQ ID NO: 1 and wherein the variant has one or more modified properties as compared with a reference polypeptide having kaurenoic acid 13-hydroxylase activity. A variant polypeptide of the invention may be used in a recombinant host for the production of steviol or a steviol glycoside.
-
公开(公告)号：US20210040491A1
公开(公告)日：2021-02-11
申请号：US16938483
申请日：2020-07-24
Applicant: DSM IP ASSETS B.V.
Abstract: The present invention relates a variant polypeptide having kaurenoic acid 13-hydroxylase activity, which variant polypeptide comprises an amino acid sequence which, when aligned with a kaurenoic acid 13-hydroxylase comprising the sequence set out in SEQ ID NO: 1, comprises at least one substitution of an amino acid residue corresponding to any of amino acids 72, 85, 108, 127, 129, 141, 172, 195, 196, 197, 199, 226, 236, 291, 302, 361 or 464, said positions being defined with reference to SEQ ID NO: 1 and wherein the variant has one or more modified properties as compared with a reference polypeptide having kaurenoic acid 13-hydroxylase activity. A variant polypeptide of the invention may be used in a recombinant host for the production of steviol or a steviol glycoside.
-
公开(公告)号：US10604743B2
公开(公告)日：2020-03-31
申请号：US15558133
申请日：2016-03-16
Applicant: DSM IP ASSETS B.V.
Inventor： Viktor Marius Boer , Johannes Gustaaf Ernst Van Leeuwen , Priscilla Zwartjens , Catharina Petronella Antonia Maria Kolen
Abstract: The present invention relates to a recombinant host comprising a recombinant nucleic acid sequence encoding a polypeptide having at least about: a. 85% identity to the amino acid sequence set forth in SEQ ID NO: 1; b. 85% identity to the amino acid sequence set forth in SEQ ID NO: 3; c. 85% identity to the amino acid sequence set forth in SEQ ID NO: 6; d. 85% identity to the amino acid sequence set forth in SEQ ID NO: 9; e. 85% identity to the amino acid sequence set forth in SEQ ID NO: 11; f. 85% identity to the amino acid sequence set forth in SEQ ID NO: 14; g. 85% identity to the amino acid sequence set forth in SEQ ID NO: 17; h. 85% identity to the amino acid sequence set forth in SEQ ID NO: 20; i. 85% identity to the amino acid sequence set forth in SEQ ID NO: 22; or j. 85% identity to the amino acid sequence set forth in SEQ ID NO: 25.
-
Patent Agency Ranking
公开(公告)号：US20150037892A1
公开(公告)日：2015-02-05
申请号：US14384192
申请日：2013-03-12
Applicant: DSM IP ASSETS B.V.
Inventor： Nathalie Wiessenhaan , Catharina Petronella Antonia Maria Kolen , Bernard Meijrink , Viktor Marius Boer , Johannes Andries Roubos , Yvonne Johannes Odilia Arendsen
IPC: C12N15/10
Abstract: The present invention relates to a method for carrying out recombination at a target locus.
Abstract translation: 本发明涉及在靶位点进行重组的方法。
-
公开(公告)号：US12091436B2
公开(公告)日：2024-09-17
申请号：US18167119
申请日：2023-02-10
Applicant: DSM IP ASSETS B.V.
Inventor： Johannes Gustaaf Ernst Van Leeuwen , Viktor Marius Boer , Priscilla Zwartjens , Jos Van Vugt , René Marcel De Jong
CPC classification number: C07K14/39 , C12N9/0042 , C12P19/56 , C12Y106/02004
Abstract: The disclosure provides a recombinant cell capable of producing a steviol glycoside, wherein the cell comprises a nucleic acid coding for a variant of a parent polypeptide, wherein the variant has steviol glycoside transport mediating activity, wherein the variant comprises an amino acid sequence which, when aligned with the amino acid sequence of the parent polypeptide, comprises at least one modification of the amino acid residue corresponding to any of the amino acids in the amino acid sequence of the parent polypeptide, wherein the variant has an improved ability to produce rebaudioside M and optionally other steviol glycosides extracellularly if compared with the parent polypeptide when measured under the same conditions.
-
公开(公告)号：US11925193B2
公开(公告)日：2024-03-12
申请号：US17512368
申请日：2021-10-27
Applicant: DSM IP ASSETS B.V.
Inventor： Viktor Marius Boer , Priscilla Zwartjens , Eric Van Den Berg
IPC: C12N1/16 , A23L2/60 , A23L27/30 , C07K14/39 , C07K14/395 , C07K14/40 , C12N9/24 , C12P15/00 , C12P19/56
CPC classification number: A23L27/36 , A23L2/60 , C07K14/39 , C07K14/395 , C07K14/40 , C12N1/16 , C12N9/2402 , C12P15/00 , C12P19/56
Abstract: A recombinant host capable of producing a steviol glycoside which overexpresses a polypeptide which mediates steviol glycoside transport and which polypeptide comprises the amino acid sequence set forth in SEQ ID NO: 29 or an amino acid sequence having at least about 50% sequence identity thereto. A recombinant host capable of producing a steviol glycoside which has been modified, preferably in its genome, to result in a deficiency in the production of a polypeptide which mediates steviol glycoside transport and which polypeptide comprises the amino acid sequence set forth in SEQ ID NO: 29 or an amino acid sequence having at least about 50% sequence identity thereto.
-
公开(公告)号：US11639497B2
公开(公告)日：2023-05-02
申请号：US16624072
申请日：2018-06-26
Applicant: DSM IP ASSETS B.V.
Inventor： Viktor Marius Boer , Johannes Gustaaf Ernst Van Leeuwen
Abstract: The present disclosure relates a polypeptide having UGT activity, which polypeptide comprises an amino acid sequence which, when aligned with a polypeptide having UGT activity comprising the sequence set out in SEQ ID NO: 2, comprises at least one substitution of an amino acid corresponding to any of amino acids at positions 35, 189, 280, 284, 285, 334 or 373, said positions being defined with reference to SEQ ID NO: 2 and wherein the polypeptide has one or more modified properties as compared with a reference polypeptide having UGT activity. A polypeptide according to the disclosure may be used in a recombinant cell for the production of steviol or a steviol glycoside.
-
公开(公告)号：US11297862B2
公开(公告)日：2022-04-12
申请号：US15751674
申请日：2016-08-15
Applicant: DSM IP ASSETS B.V.
Inventor： Viktor Marius Boer , Priscilla Zwartjens , Eric Van Den Berg
IPC: C07K14/39 , C12P19/56 , A23L27/30 , A23L2/60 , C12P15/00 , C07K14/395 , C07K14/40 , C12N1/16 , C12N9/24
Abstract: A recombinant host capable of producing a steviol glycoside which overexpresses a polypeptide which mediates steviol glycoside transport and which polypeptide comprises the amino acid sequence set forth in SEQ ID NO: 29 or an amino acid sequence having at least about 50% sequence identity thereto. A recombinant host capable of producing a steviol glycoside which has been modified, preferably in its genome, to result in a deficiency in the production of a polypeptide which mediates steviol glycoside transport and which polypeptide comprises the amino acid sequence set forth in SEQ ID NO: 29 or an amino acid sequence having at least about 50% sequence identity thereto.
-
-
-
-
-
-
-
-
-
Search Results
23
records
(took 0.019 seconds)
